LYTIR

Company · NTRA

Natera, Inc.

Nasdaq's symbol directory lists NTRA on Nasdaq as “Natera, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 77 occasions ($162.2M); 32 planned-sale notices; 3 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 27, No. 26

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $162.2M in total.Jun: Insider sales $35.7MJul: Insider sales $11.8MAug: Insider sales $9.9MSep: Insider sales $67.9MOct: Insider sales $31.6MNov: Insider sales $5.4MDecJanFebMarAprMayJunJulAugSepOctNov$67.9M
Insider purchases above the line: $0Insider sales below: $162.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Rabinowitz Matthew, EXECUTIVE CHAIRMAN sold on 12 days all under a 10b5-1 plan latest Nov 2, 2026 sold $95.3M
  2. Sheena Jonathan sold on 19 days all under a 10b5-1 plan latest Nov 11, 2026 sold $21.1M
  3. RABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER sold on 8 days all under a 10b5-1 plan latest Nov 2, 2026 sold $14.5M
  4. Moshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold on 10 days all under a 10b5-1 plan latest Nov 2, 2026 sold $11.8M
  5. Chapman Steven Leonard, CEO AND PRESIDENT sold on 8 days all under a 10b5-1 plan latest Nov 2, 2026 sold $7.3M
  6. ROSENMAN HERM sold on 1 day all under a 10b5-1 plan latest Jun 24, 2026 sold $4.1M
  7. Brophy Michael Burkes, CHIEF FINANCIAL OFFICER sold on 10 days all under a 10b5-1 plan latest Nov 3, 2026 sold $4.0M
  8. Fesko John, PRESIDENT, CHIEF BUS. OFFICER sold on 7 days all under a 10b5-1 plan latest Nov 2, 2026 sold $3.4M
  9. Chapman Rowan E sold on 2 days all under a 10b5-1 plan latest Jul 15, 2026 sold $680K
Every trade (77)
  1. SELLSheena Jonathan sold Nov 11, 2026 1,500 shares 14 legs combined 10b5-1 plan (scheduled) filing $479K
  2. SELLSheena Jonathan sold Nov 6, 2026 3,150 shares 19 legs combined 10b5-1 plan (scheduled) filing $995K
  3. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Nov 3, 2026 470 shares 10b5-1 plan (scheduled) filing $184K
  4. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Nov 2, 2026 3,801 shares 3 legs combined 10b5-1 plan (scheduled) filing $1.6M
  5. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Nov 2, 2026 3,419 shares 12 legs combined 10b5-1 plan (scheduled) filing $1.4M
  6. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Nov 2, 2026 748 shares 2 legs combined 10b5-1 plan (scheduled) filing $299K
  7. SELLRABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER sold Nov 2, 2026 341 shares 2 legs combined 10b5-1 plan (scheduled) filing $136K
  8. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Nov 2, 2026 325 shares 2 legs combined 10b5-1 plan (scheduled) filing $130K
  9. SELLFesko John, PRESIDENT, CHIEF BUS. OFFICER sold Nov 2, 2026 302 shares 2 legs combined 10b5-1 plan (scheduled) filing $121K
  10. SELLSheena Jonathan sold Nov 2, 2026 112 shares 2 legs combined 10b5-1 plan (scheduled) filing $45K
  11. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Oct 30, 2026 1,906 shares 10b5-1 plan (scheduled) filing $811K
  12. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Oct 28, 2026 3,430 shares 10b5-1 plan (scheduled) filing $1.5M
  13. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Oct 28, 2026 2,376 shares 3 legs combined 10b5-1 plan (scheduled) filing $1.0M
  14. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Oct 28, 2026 1,162 shares 10b5-1 plan (scheduled) filing $495K
  15. SELLRABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER sold Oct 28, 2026 968 shares 10b5-1 plan (scheduled) filing $413K
  16. SELLFesko John, PRESIDENT, CHIEF BUS. OFFICER sold Oct 28, 2026 898 shares 10b5-1 plan (scheduled) filing $383K
  17. SELLSheena Jonathan sold Oct 28, 2026 187 shares 10b5-1 plan (scheduled) filing $80K
  18. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Oct 27, 2026 2,264 shares 10b5-1 plan (scheduled) filing $919K
  19. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Oct 27, 2026 1,718 shares 10b5-1 plan (scheduled) filing $698K
  20. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Oct 27, 2026 1,010 shares 10b5-1 plan (scheduled) filing $410K
  21. SELLRABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER sold Oct 27, 2026 884 shares 10b5-1 plan (scheduled) filing $359K
  22. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Oct 27, 2026 781 shares 10b5-1 plan (scheduled) filing $317K
  23. SELLFesko John, PRESIDENT, CHIEF BUS. OFFICER sold Oct 27, 2026 781 shares 10b5-1 plan (scheduled) filing $317K
  24. SELLSheena Jonathan sold Oct 27, 2026 291 shares 10b5-1 plan (scheduled) filing $118K
  25. SELLSheena Jonathan sold Oct 21, 2026 3,150 shares 8 legs combined 10b5-1 plan (scheduled) filing $1.3M
  26. SELLSheena Jonathan sold Oct 16, 2026 1,500 shares 12 legs combined 10b5-1 plan (scheduled) filing $604K
  27. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Oct 15, 2026 50,000 shares 19 legs combined 10b5-1 plan (scheduled) filing $20.1M
  28. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Oct 1, 2026 3,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $1.2M
  29. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Oct 1, 2026 1,273 shares 10b5-1 plan (scheduled) filing $526K
  30. SELLSheena Jonathan sold Sep 23, 2026 18,064 shares 12 legs combined 10b5-1 plan (scheduled) filing $7.0M
  31. SELLSheena Jonathan sold Sep 16, 2026 3,150 shares 6 legs combined 10b5-1 plan (scheduled) filing $1.1M
  32. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Sep 15, 2026 52,000 shares 14 legs combined 10b5-1 plan (scheduled) filing $18.1M
  33. SELLSheena Jonathan sold Sep 15, 2026 6,000 shares 10b5-1 plan (scheduled) filing $2.1M
  34. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Sep 14, 2026 50,000 shares 15 legs combined 10b5-1 plan (scheduled) filing $16.7M
  35. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Sep 11, 2026 50,000 shares 6 legs combined 10b5-1 plan (scheduled) filing $16.4M
  36. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Sep 2, 2026 15,160 shares 10b5-1 plan (scheduled) filing $5.0M
  37. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Sep 1, 2026 3,000 shares 3 legs combined 10b5-1 plan (scheduled) filing $962K
  38. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Sep 1, 2026 1,698 shares 10b5-1 plan (scheduled) filing $545K
  39. SELLFesko John, PRESIDENT, CHIEF BUS. OFFICER sold Aug 10, 2026 6,517 shares 10b5-1 plan (scheduled) filing $2.1M
  40. SELLSheena Jonathan sold Aug 10, 2026 6,000 shares 10b5-1 plan (scheduled) filing $2.0M
  41. SELLSheena Jonathan sold Aug 7, 2026 9,150 shares 10 legs combined 10b5-1 plan (scheduled) filing $2.9M
  42. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Aug 7, 2026 2,000 shares 10b5-1 plan (scheduled) filing $642K
  43. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Aug 4, 2026 478 shares 10b5-1 plan (scheduled) filing $131K
  44. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Aug 3, 2026 3,410 shares 7 legs combined 10b5-1 plan (scheduled) filing $906K
  45. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Aug 3, 2026 3,076 shares 7 legs combined 10b5-1 plan (scheduled) filing $819K
  46. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Aug 3, 2026 731 shares 10b5-1 plan (scheduled) filing $196K
  47. SELLRABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER sold Aug 3, 2026 334 shares 10b5-1 plan (scheduled) filing $90K
  48. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Aug 3, 2026 317 shares 10b5-1 plan (scheduled) filing $85K
  49. SELLFesko John, PRESIDENT, CHIEF BUS. OFFICER sold Aug 3, 2026 295 shares 10b5-1 plan (scheduled) filing $79K
  50. SELLSheena Jonathan sold Aug 3, 2026 109 shares 10b5-1 plan (scheduled) filing $29K
  51. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Jul 29, 2026 1,863 shares 10b5-1 plan (scheduled) filing $465K
  52. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Jul 28, 2026 3,580 shares 10b5-1 plan (scheduled) filing $910K
  53. SELLBrophy Michael Burkes, CHIEF FINANCIAL OFFICER sold Jul 28, 2026 2,419 shares 3 legs combined 10b5-1 plan (scheduled) filing $614K
  54. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Jul 28, 2026 1,204 shares 10b5-1 plan (scheduled) filing $306K
  55. SELLRABINOWITZ DANIEL, SEC. AND CHIEF LEGAL OFFICER sold Jul 28, 2026 1,003 shares 10b5-1 plan (scheduled) filing $255K
  56. SELLFesko John, PRESIDENT, CHIEF BUS. OFFICER sold Jul 28, 2026 931 shares 10b5-1 plan (scheduled) filing $237K
  57. SELLSheena Jonathan sold Jul 28, 2026 191 shares 10b5-1 plan (scheduled) filing $49K
  58. SELLChapman Steven Leonard, CEO AND PRESIDENT sold Jul 27, 2026 2,190 shares 10b5-1 plan (scheduled) filing $570K
  59. SELLRabinowitz Matthew, EXECUTIVE CHAIRMAN sold Jul 27, 2026 1,718 shares 10b5-1 plan (scheduled) filing $448K
  60. SELLMoshkevich Solomon, PRESIDENT, CLINICALDIAGNOSTICS sold Jul 27, 2026 1,010 shares 10b5-1 plan (scheduled) filing $263K

Showing the latest 60 of 77.

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. MICHAEL BROPHY filed Nov 3, 2026 Officer 470 shares planned sale date 11/03/2026 filing $178K
  2. SOLOMON MOSHKEVICH filed Nov 2, 2026 Officer 3,000 shares planned sale date 11/02/2026 filing $1.2M
  3. STEVEN L CHAPMAN filed Nov 2, 2026 Officer 2,866 shares planned sale date 11/02/2026 filing $1.2M
  4. STEVEN CHAPMAN filed Nov 2, 2026 OFFICER 903 shares planned sale date 11/02/2026 filing $374K
  5. MATTHEW RABINOWITZ filed Nov 2, 2026 DIRECTOR 722 shares planned sale date 11/02/2026 filing $299K
  6. SOLOMON MOSHKEVICH filed Nov 2, 2026 OFFICER 405 shares planned sale date 11/02/2026 filing $168K
  7. DANIEL RABINOWITZ filed Nov 2, 2026 OFFICER 330 shares planned sale date 11/02/2026 filing $137K
  8. MICHAEL BROPHY filed Nov 2, 2026 OFFICER 313 shares planned sale date 11/02/2026 filing $130K
  9. JOHN FESKO filed Nov 2, 2026 OFFICER 291 shares planned sale date 11/02/2026 filing $121K
  10. JONATHAN SHEENA filed Nov 2, 2026 DIRECTOR 108 shares planned sale date 11/02/2026 filing $45K
  11. MICHAEL BROPHY filed Oct 30, 2026 Officer 1,906 shares planned sale date 10/30/2026 filing $831K
  12. STEVEN CHAPMAN filed Oct 28, 2026 OFFICER 3,499 shares planned sale date 10/28/2026 filing $1.4M
  13. MICHAEL BROPHY filed Oct 28, 2026 OFFICER 1,222 shares planned sale date 10/28/2026 filing $502K
  14. SOLOMON MOSHKEVICH filed Oct 28, 2026 OFFICER 1,185 shares planned sale date 10/28/2026 filing $487K
  15. MICHAEL BROPHY filed Oct 28, 2026 Officer 1,178 shares planned sale date 10/28/2026 filing $484K
  16. DANIEL RABINOWITZ filed Oct 28, 2026 OFFICER 988 shares planned sale date 10/28/2026 filing $406K
  17. JOHN FESKO filed Oct 28, 2026 OFFICER 917 shares planned sale date 10/28/2026 filing $377K
  18. JONATHAN SHEENA filed Oct 28, 2026 DIRECTOR 191 shares planned sale date 10/28/2026 filing $78K
  19. STEVEN CHAPMAN filed Oct 27, 2026 OFFICER 2,236 shares planned sale date 10/27/2026 filing $905K
  20. MATTHEW RABINOWITZ filed Oct 27, 2026 DIRECTOR 1,697 shares planned sale date 10/27/2026 filing $687K
  21. SOLOMON MOSHKEVICH filed Oct 27, 2026 OFFICER 997 shares planned sale date 10/27/2026 filing $404K
  22. DANIEL RABINOWITZ filed Oct 27, 2026 OFFICER 873 shares planned sale date 10/27/2026 filing $353K
  23. MICHAEL BROPHY filed Oct 27, 2026 OFFICER 771 shares planned sale date 10/27/2026 filing $312K
  24. JOHN FESKO filed Oct 27, 2026 OFFICER 771 shares planned sale date 10/27/2026 filing $312K
  25. JONATHAN SHEENA filed Oct 27, 2026 DIRECTOR 287 shares planned sale date 10/27/2026 filing $116K
  26. Sheena Jonathan filed Oct 21, 2026 Director 9,450 shares planned sale date 10/21/2026 filing $3.9M
  27. MATTHEW RABINOWITZ filed Oct 15, 2026 Director 50,000 shares planned sale date 10/15/2026 filing $19.7M
  28. SOLOMON MOSHKEVICH filed Oct 1, 2026 Officer 3,000 shares planned sale date 10/01/2026 filing $1.2M
  29. STEVEN L CHAPMAN filed Oct 1, 2026 Officer 1,273 shares planned sale date 10/01/2026 filing $526K
  30. Sheena Jonathan filed Sep 23, 2026 Director 21,064 shares planned sale date 09/23/2026 filing $8.2M
  31. TINKERBELLE II TR U/A DTD 10/22/2021 filed Sep 15, 2026 Officer 2,000 shares planned sale date 09/15/2026 filing $700K
  32. MATTHEW RABINOWITZ filed Sep 11, 2026 Director 200,000 shares planned sale date 09/11/2026 filing $65.2M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FMR LLC filed Nov 6, 2026 Schedule 13G/A passive 15,131,244 shares filing 10.5%
  2. FMR LLC filed Nov 5, 2026 Schedule 13G passive 13,659,508 shares filing 9.5%
  3. T. Rowe Price Associates, Inc. filed Aug 14, 2026 Schedule 13G/A passive 9,021,825 shares filing 6.3%

Executive branch · OGE Form 278-T

Reported by the President

6 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Purchase: NATERA INC Jul 17, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $1,001 – $15,000
  2. Purchase: NATERA INC Jun 15, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  3. Purchase: NATERA INC May 18, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  4. Purchase: NATERA INC May 15, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $1,001 – $15,000
  5. Sale: NATERA INC Mar 17, 2026 reported May 8, 2026 President Donald J. Trump Periodic Transaction Report 05.08.26 (1) $1,001 – $15,000
  6. Sale: NATERA INC Feb 19, 2026 reported May 8, 2026 President Donald J. Trump Periodic Transaction Report 05.08.26 (1) $1,001 – $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026

Lobbying · Senate LDA reports

Lobbying filed

5 quarterly lobbying reports for 2026 naming Natera, Inc. as the client: 1 filed by the company itself, 4 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. LMH STRATEGIC SOLUTIONS Q2 2026 filing no amount stated
  2. The company itself Q1 2026 filing $150K
  3. THE CONSILIO GROUP Q1 2026 filing $54K
  4. ERVIN GRAVES STRATEGY GROUP, LLC Q1 2026 filing $30K
  5. ERVIN GRAVES STRATEGY GROUP, LLC Q1 2026 filing no amount stated

Federal contracts · USAspending.gov

Federal contracts

7 contract awards first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $1.1M in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.

  1. Department of Veterans Affairs Jan 7, 2026 to NATERA INC award $448K
  2. Department of Veterans Affairs Oct 1, 2026 to NATERA INC award $230K
  3. Department of Veterans Affairs Apr 7, 2026 to NATERA INC award $157K
  4. Department of Veterans Affairs Jul 10, 2026 to NATERA INC award $110K
  5. Department of Veterans Affairs Mar 4, 2026 to NATERA INC award $74K
  6. Department of Veterans Affairs Aug 3, 2026 to NATERA INC award $48K
  7. Department of Veterans Affairs Aug 27, 2026 to NATERA INC award $40K

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, USAspending.gov, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.